GAMMA Investing’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.8K Buy
1,121
+196
+21% +$8.22K ﹤0.01% 2115
2026
Q1
$29.8K Sell
925
-529
-36% -$19.6K ﹤0.01% 2500
2025
Q4
$61.2K Buy
1,454
+864
+146% +$34.8K ﹤0.01% 1931
2025
Q3
$20.3K Buy
590
+278
+89% +$7.98K ﹤0.01% 2503
2025
Q2
$8.43K Sell
312
-338
-52% -$9.79K ﹤0.01% 2896
2025
Q1
$19.3K Buy
650
+217
+50% +$8.27K ﹤0.01% 2401
2024
Q4
$17.1K Buy
433
+154
+55% +$5.83K ﹤0.01% 2348
2024
Q3
$9.5K Buy
279
+199
+249% +$5.6K ﹤0.01% 2485
2024
Q2
$1.73K Sell
80
-39
-33% -$820 ﹤0.01% 2921
2024
Q1
$2.64K Buy
119
+78
+190% +$1.9K ﹤0.01% 2660
2023
Q4
$1.03K Buy
+41
New +$990 ﹤0.01% 2781

Other funds holding VCYT

GAMMA Investing's VCYT Position: Q2 2026 in Review

GAMMA Investing increased its Veracyte (VCYT) stake by 21% in Q2 2026, buying an estimated $8.22K and bringing the position to 1,121 shares worth $65.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

GAMMA Investing first reported a position in VCYT in Q4 2023 and has held it in 11 quarters since. 34 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • GAMMA Investing held 1,121 shares of Veracyte worth $65.8K as of Q2 2026.
  • GAMMA Investing bought 196 Veracyte shares in Q2 2026, an estimated $8.22K.
  • Veracyte made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2115 holding.
  • GAMMA Investing first reported a position in Veracyte in Q4 2023 and has held it in 11 quarters since.
  • 34 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.